Compugen Ltd.
CGEN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $2 | $1 | $2 | $1 |
| % Growth | 50.4% | -45% | 55.3% | – |
| Cost of Goods Sold | $2 | $2 | $2 | $1 |
| Gross Profit | $0 | -$0 | -$0 | $1 |
| % Margin | 12.7% | -32.5% | -5.1% | 54.1% |
| R&D Expenses | $6 | $6 | $6 | $6 |
| G&A Expenses | $0 | $2 | $2 | $2 |
| SG&A Expenses | $2 | $2 | $3 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $8 | $8 | $8 | $8 |
| Operating Income | -$8 | -$8 | -$8 | -$7 |
| % Margin | -417.4% | -670.6% | -367.6% | -508.7% |
| Other Income/Exp. Net | $1 | $1 | $1 | $1 |
| Pre-Tax Income | -$7 | -$7 | -$7 | -$6 |
| Tax Expense | $0 | -$0 | $0 | $0 |
| Net Income | -$7 | -$7 | -$7 | -$6 |
| % Margin | -369.1% | -584.1% | -314.4% | -415.8% |
| EPS | -0.075 | -0.079 | -0.078 | -0.068 |
| % Growth | 5% | -0.9% | -13.9% | – |
| EPS Diluted | -0.075 | -0.079 | -0.078 | -0.068 |
| Weighted Avg Shares Out | 94 | 94 | 92 | 90 |
| Weighted Avg Shares Out Dil | 94 | 94 | 92 | 90 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $1 | $1 | $1 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$7 | -$7 | -$8 | -$7 |
| % Margin | -366.9% | -585.4% | -367.6% | -508.7% |